Back

Glomerular filtration rate predicts pro-vascular progenitor cell depletion: insights from the IPE-PREVENTION and ORIGINS-RCE studies

25 August 2023 (16:15 - 16:50)
Organised by: Logo
Congress Presentation Part of: Renal failure and clinical outcomes Renal Failure and Cardiovascular Disease ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Mr Ehab Bakbak

St. Michael's Hospital, Toronto (Canada)

6 More presentations in this session

Presentation thumbnail
Impact of coronary flow reserve on the mortality and major adverse cardiac and cerebrovascular event in hemodialysis patients, regardless of diabetes.
Doctor S. Ohshima (Nagoya, JP)
Abstract Slides Video
Presentation thumbnail
Development, validation, and comparative analysis of a simple clinical and laboratory-based risk score system for predicting and stratifying moderate-to-severe AKI after cardiac surgery
Doctor J. Zeng (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
Impact of mildly reduced kidney function on 5-year mortality in patients with STEMI treated with primary PCI
Doctor M. Klaric (Belgrade, RS)
Abstract Slides Video
Presentation thumbnail
Incidence of major cardiovascular outcomes in patients with chronic kidney disease by severity: a United States population-based study using electronic medical records
Doctor B. Tyl (La Garenne Colombes Cedex, FR)
Abstract Slides Video
Presentation thumbnail
Prolonged fibrinolysis time is a risk factor for mortality in patients with chronic kidney disease - a propensity score matched analysis
Doctor M. Berger (Aachen, DE)
Abstract Slides Video

Access the full session

Session thumbnail
Renal failure and clinical outcomes

The Event

Event poster

ESC Congress 2023

25 August 2023 16:15 CET
You may be interested in
thumbnail
Congress Presentation
Vascular regenerative cell content in people with elevated lipoprotein(a): primary results of the Lp(a)-VRCE study
thumbnail
Congress Presentation
Association between estimated glomerular filtration rate and prognosis in patients with cardiovascular disease with and without sarcopenia
thumbnail
Congress Presentation
Semaglutide promotes vascular repair mechanisms

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources